Jon Cuthbert

TD SYNNEX (NYSE:SNX) today announced robust financial results for its fiscal fourth quarter ended November 30, 2025, demonstrating solid growth across key metrics.

Paramount (NASDAQ:PSKY) reaffirmed its $30-per-share cash offer for Warner Bros. Discovery on Thursday, resisting pressure to sweeten the deal even after WBD’s board dismissed the proposal as a risky "leveraged buyout."

Viking Therapeutics (NASDAQ:VKTX) finished enrolling patients in a clinical trial designed to test how different dosing schedules of its experimental obesity drug can help people keep weight off, a key step in its bid to compete with established giants in the metabolic space.

Lindsay Corporation (NYSE:LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today reported its financial results for the first quarter of fiscal 2026, ended November 30, 2025.

The Competition Commission of India (CCI) told the Delhi High Court that calculating antitrust fines based on a company’s global turnover is essential to prevent multinational corporations from treating penalties as a "nominal" cost of doing business.

Evotec SE (NASDAQ:EVO) announced that its Seattle-based subsidiary, Just – Evotec Biologics, has received a new grant (INV072135) from the Bill & Melinda Gates Foundation to accelerate the development of affordable biologics for low- and middle-income countries.

Bitwise says legislative progress and market stability will decide whether crypto hits new records in 2026.

CryptoQuant says Bitcoin could face a dull sideways phase in early 2026 as investor capital shifts elsewhere.

Iran says it can accept crypto for weapons exports, though analysts warn the system may be more symbolic than operational.

Elon Musk argues Nvidia’s self-driving advances will not threaten Tesla’s lead for several more years.